Drug Controller General of India Approval to Covaxin for children aged between 2-18 years awaited after evaluation of data Newsroom Staff October 12, 2021
Drug Controller General of India CSIR to begin two clinical drug trials to combat COVID-19 Newsroom Staff October 12, 2021
